Literature DB >> 29713834

The Phenotypic Effects of Exosomes Secreted from Distinct Cellular Sources: a Comparative Study Based on miRNA Composition.

Scott Ferguson1, Sera Kim1, Christine Lee1, Michael Deci1, Juliane Nguyen2.   

Abstract

Exosomes are nano-sized vesicles composed of lipids, proteins, and nucleic acids. Their molecular landscape is diverse, and exosomes derived from different cell types have distinct biological activities. Since exosomes are now being utilized as delivery vehicles for exogenous therapeutic cargoes, their intrinsic properties and biological effects must be understood. We performed miRNA profiling and found substantial differences in the miRNA landscape of prostate cancer (PC3) and human embryonic kidney (HEK) 293 exosomes with little correlation in abundance of common miRNAs (R2 = 0.16). Using a systems-level bioinformatics approach, the most abundant miRNAs in PC3 exosomes but not HEK exosomes were predicted to significantly modulate integrin signaling, with integrin-β3 loss inducing macrophage M2 polarization. PC3 but not HEK exosomes downregulated integrin-β3 expression levels by 70%. There was a dose-dependent polarization of RAW 264.7 macrophages toward an M2 phenotype when treated with PC3-derived exosomes but not HEK-derived exosomes. Conversely, HEK exosomes, widely utilized as delivery vehicles, were predicted to target cadherin signaling, with experimental validation showing a significant increase in the migratory potential of MCF7 breast cancer cells treated with HEK exosomes. Even widely utilized exosomes are unlikely to be inert, and their intrinsic activity ought to be assessed before therapeutic deployment.

Entities:  

Keywords:  M2 polarization; cadherin signaling; exosomes; miRNA profiling; phenotypic effects

Mesh:

Substances:

Year:  2018        PMID: 29713834      PMCID: PMC6461218          DOI: 10.1208/s12248-018-0227-4

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  61 in total

1.  Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy.

Authors:  Viktoriya Sokolova; Anna-Kristin Ludwig; Sandra Hornung; Olga Rotan; Peter A Horn; Matthias Epple; Bernd Giebel
Journal:  Colloids Surf B Biointerfaces       Date:  2011-05-12       Impact factor: 5.268

2.  Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury.

Authors:  Ruenn Chai Lai; Fatih Arslan; May May Lee; Newman Siu Kwan Sze; Andre Choo; Tian Sheng Chen; Manuel Salto-Tellez; Leo Timmers; Chuen Neng Lee; Reida Menshawe El Oakley; Gerard Pasterkamp; Dominique P V de Kleijn; Sai Kiang Lim
Journal:  Stem Cell Res       Date:  2010-01-04       Impact factor: 2.020

3.  Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis.

Authors:  Weiying Zhou; Miranda Y Fong; Yongfen Min; George Somlo; Liang Liu; Melanie R Palomares; Yang Yu; Amy Chow; Sean Timothy Francis O'Connor; Andrew R Chin; Yun Yen; Yafan Wang; Eric G Marcusson; Peiguo Chu; Jun Wu; Xiwei Wu; Arthur Xuejun Li; Zhuo Li; Hanlin Gao; Xiubao Ren; Mark P Boldin; Pengnian Charles Lin; Shizhen Emily Wang
Journal:  Cancer Cell       Date:  2014-04-14       Impact factor: 31.743

4.  Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells.

Authors:  Hiroko Tadokoro; Tomohiro Umezu; Kazuma Ohyashiki; Toshihiko Hirano; Junko H Ohyashiki
Journal:  J Biol Chem       Date:  2013-10-16       Impact factor: 5.157

5.  Differences in integrin expression and signaling within human breast cancer cells.

Authors:  Aliakbar Taherian; Xinlei Li; Yongqing Liu; Thomas A Haas
Journal:  BMC Cancer       Date:  2011-07-13       Impact factor: 4.430

Review 6.  Exosomes in cancer: small particle, big player.

Authors:  Xu Zhang; Xiao Yuan; Hui Shi; Lijun Wu; Hui Qian; Wenrong Xu
Journal:  J Hematol Oncol       Date:  2015-07-10       Impact factor: 17.388

Review 7.  Metabolism via Arginase or Nitric Oxide Synthase: Two Competing Arginine Pathways in Macrophages.

Authors:  Meera Rath; Ingrid Müller; Pascale Kropf; Ellen I Closs; Markus Munder
Journal:  Front Immunol       Date:  2014-10-27       Impact factor: 7.561

8.  Exosomes released from breast cancer carcinomas stimulate cell movement.

Authors:  Dinari A Harris; Sajni H Patel; Marjan Gucek; An Hendrix; Wendy Westbroek; Justin W Taraska
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

9.  Pretreatment of Cardiac Stem Cells With Exosomes Derived From Mesenchymal Stem Cells Enhances Myocardial Repair.

Authors:  Zhiwei Zhang; Junjie Yang; Weiya Yan; Yangxin Li; Zhenya Shen; Takayuki Asahara
Journal:  J Am Heart Assoc       Date:  2016-01-25       Impact factor: 5.501

Review 10.  Molecular signatures of mesenchymal stem cell-derived extracellular vesicle-mediated tissue repair.

Authors:  Takeshi Katsuda; Takahiro Ochiya
Journal:  Stem Cell Res Ther       Date:  2015-11-11       Impact factor: 6.832

View more
  7 in total

1.  MiR-101a loaded extracellular nanovesicles as bioactive carriers for cardiac repair.

Authors:  Jinli Wang; Christine J Lee; Michael B Deci; Natalie Jasiewicz; Anjali Verma; John M Canty; Juliane Nguyen
Journal:  Nanomedicine       Date:  2020-04-08       Impact factor: 5.307

Review 2.  Role of Exosomes for Delivery of Chemotherapeutic Drugs.

Authors:  Aragaw Gebeyehu; Nagavendra Kommineni; David G Meckes; Mandip Singh Sachdeva
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2021       Impact factor: 4.889

3.  Harnessing the Full Potential of Extracellular Vesicles as Drug Carriers.

Authors:  Natalie Jasiewicz; Corinne Drabenstott; Juliane Nguyen
Journal:  Curr Opin Colloid Interface Sci       Date:  2020-12-19       Impact factor: 8.209

Review 4.  Role of exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironment.

Authors:  Zijie Xu; Yi Chen; Ling Ma; Yizhang Chen; Jingya Liu; Yuchen Guo; Ting Yu; Lianghui Zhang; Lingjun Zhu; Yongqian Shu
Journal:  Mol Ther       Date:  2022-04-09       Impact factor: 12.910

Review 5.  Advances in Exosome-Based Drug Delivery and Tumor Targeting: From Tissue Distribution to Intracellular Fate.

Authors:  Juntang Shao; Jennica Zaro; Yuxian Shen
Journal:  Int J Nanomedicine       Date:  2020-11-24

6.  Carrier-Free CXCR4-Targeted Nanoplexes Designed for Polarizing Macrophages to Suppress Tumor Growth.

Authors:  Michael B Deci; Maixian Liu; Jacqueline Gonya; Christine J Lee; Tingyi Li; Scott W Ferguson; Emily E Bonacquisti; Jinli Wang; Juliane Nguyen
Journal:  Cell Mol Bioeng       Date:  2019-08-27       Impact factor: 2.321

7.  Boosting the Biogenesis and Secretion of Mesenchymal Stem Cell-Derived Exosomes.

Authors:  Jinli Wang; Emily E Bonacquisti; Adam D Brown; Juliane Nguyen
Journal:  Cells       Date:  2020-03-09       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.